Advancing the Paradigm: Oligometastatic Disease and the Impact of Stereotactic Ablative Body Radiotherapy

Clin Oncol (R Coll Radiol). 2024 Mar 26:S0936-6555(24)00134-1. doi: 10.1016/j.clon.2024.03.023. Online ahead of print.

Authors

D Shor¹, V Khoo², K T Jayaprakash³

Affiliations

¹ Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK. Electronic address: drdanashor@gmail.com.
² The Royal Marsden Hospital NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK.
³ Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, Kings Lynn, UK.

PMID: 38631977
DOI: 10.1016/j.clon.2024.03.023

No abstract available

Keywords: Oligometastases; quality of life; stereotatic ablative body radiotherapy.

Publication types

Editorial